SHL TeleMedicine Ltd. | Balance Sheet

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
25,251.30
17,554.80
8,564.60
10,733.70
10,129.00
8,724.30
Total Accounts Receivable
14,821.00
18,602.10
8,322.30
11,345.50
14,079.60
12,917.90
Inventories
772.80
2,467.20
2,768.80
2,427.00
2,151.70
1,284.50
Other Current Assets
1,625.70
1,259.90
728.70
810.00
736.70
-
Total Current Assets
42,470.90
39,884.10
20,384.40
25,316.30
27,096.90
22,926.80
Net Property, Plant & Equipment
14,213.60
12,572.70
7,544.50
5,614.30
4,819.90
3,492.70
Intangible Assets
29,478.40
28,534.60
31,112.10
26,065.30
25,663.50
22,442.70
Other Assets
4,839.80
5,812.90
3,859.90
3,390.50
3,445.80
3,252.20
Total Assets
96,507.80
91,542.00
66,915.80
63,653.00
63,832.70
54,738.50
ST Debt & Current Portion LT Debt
9,317.70
10,179.00
10,361.40
14,152.70
12,590.50
Accounts Payable
1,274.40
976.80
1,016.00
1,153.60
933.60
Income Tax Payable
-
-
-
2,211.60
9,595.90
Other Current Liabilities
6,583.00
5,109.30
9,466.50
8,594.30
8,964.40
Total Current Liabilities
17,175.10
16,265.10
20,843.80
26,112.10
32,084.40
Long-Term Debt
16,190.60
12,848.90
9,457.40
9,714.30
1,448.10
Provision for Risks & Charges
715.90
753.20
776.80
904.60
808.80
Deferred Taxes
5,505.10
4,737.70
2,937.90
2,470.70
2,139.00
Other Liabilities
1,141.00
668.70
523.50
1,921.90
359.60
Total Liabilities
35,222.70
30,535.90
32,678.60
39,448.60
35,368.50
Common Equity (Total)
61,285.10
61,006.10
34,237.20
24,204.40
28,464.20
Total Shareholders' Equity
61,285.10
61,006.10
34,237.20
24,204.40
28,464.20
Total Equity
61,285.10
61,006.10
34,237.20
24,204.40
28,464.20
Liabilities & Shareholders' Equity
96,507.80
91,542.00
66,915.80
63,653.00
63,832.70

About SHL TeleMedicine

View Profile
Address
Ashdar Building
Tel Aviv TA 67891
Israel
Employees -
Website http://www.shl-telemedicine.com
Updated 07/08/2019
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease, and cardiac monitoring services. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.